We describe the case of a 33-year-old patient with cutaneous lupus erythematosus admitted to the Department of Neurology due to the weakness of right limbs and speech disorders after night sleep. On admission, neurological examination revealed: no verbal contact; mixed aphasia with motor predominance; wide, symmetrical and reactive pupils; conjugate gaze palsy in a horizontal direction; right-sided hemianopsia and right-sided pyramidal tract syndrome with right limbs paralysis and bilaterally positive Babinski's sign. Magnetic resonance imaging revealed changes in the type of fresh ischemia in the left hemisphere of the brain – in the temporal lobe / basal ganglia on the left side hyperintensive areas were visible. As a result of the therapy and rehabilitation, the patient's general and neurological condition was improved. The patient was discharged home with recommendations in good general condition.

cutaneous lupus erythematosus; ischemic stroke

Okon LG, Werth VP. Cutaneous lupus erythematosus: diagnosis and treatment. Best Pract Res Clin Rheumatol. 2013 Jun;27(3):391-404.

Tebbe B, Orphanos CE. Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 1997;6:96–104.

Lee LA, Werth VP. Lupus erythematosus. In: Bolognia JL, editor. Dermatology. 3rd ed. London: Elsevier Ltd; 2012. p. 601.

Bruce IN. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology (Oxford, England) 2005;44(12):1492e502.

Esdaile JM, Abrahamowicz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2331–2337.

Rahman P, Urowitz MB, Gladman DD, et al. Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus. J Rheumatol 1999;26(11):2363e8.

Croca S, Rahman A. Atherosclerosis in systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2017 Jun;31(3):364-372.

Asanuma Y, Oeser A, Shintani AK, et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349(25):2407e15.

Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349(25):2399e406.

Manzi S, Selzer F, Sutton-Tyrrell K, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthr Rheum 1999;42(1):51e60.

Farzaneh-Far A, Roman MJ, Lockshin MD, et al. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. Arthr Rheum 2006;54(12):3918e25.

Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham study. Am J Epidemiol 1997; 145: 408–415.

Nightingale AL, Farmer RD. Ischemic stroke in young women: A nested case-control study using the UK General Practice Research Database. Stroke 2004; 35: 1574–1578.

Chiu CC, Huang CC, Chan WL, et al. Increased risk of ischemic stroke in patients with systemic lupus erythematosus: A nationwide population-based study. Intern Med 2012; 51: 17–21.

Mok CC, Ho LY, To CH. Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus. Scand J Rheumatol 2009; 38: 362–368.

Urowitz MB, Gladman D, Iban˜ez D, et al. Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2010; 62: 881–887.

Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: The bimodal pattern revisited. Q J Med 1985; 55: 87–98.

Jonsson H, Nived O, Sturfelt G. Outcome in systemic lupus erythematosus: A prospective study of patients from a defined population. Medicine 1989; 68: 141–150.

Krishnan E. Stroke subtypes among young patients with systemic lupus erythematosus. Am J Med 2005; 118: 1415.

Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 338–346.

Futrell N, Millikan C. Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus. Stroke 1989; 20: 583–591.

Timlin H, Petri M. Transient ischemic attack and stroke in systemic lupus erythematosus. Lupus. 2013 Oct;22(12):1251-8.

Scharre D, Petri M, Engman E, DeArmond S. Large intracranial arteritis with giant cells in systemic lupus erythematosus. Ann Intern Med 1986; 104: 661–662.

West SG. Neuropsychiatric lupus. Rheum Dis Clin North Am 1994; 20: 129–158.

Jarukitsopa S, Hoganson DD, Crowson CS, Sokumbi O, Davis MD, Michet CJ, Jr., et al. Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States. Arthritis Care Res (Hoboken). 2015;67(6):817-28.

Singh AG, Crowson CS, Singh S, Denis M, Davis P, Maradit-Kremers H, Matteson EL, Chowdhary VR. Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Cutaneous Lupus Erythematosus: A Population-Based Cohort Study. Arthritis Care Res (Hoboken). 2016 Nov;68(11):1664-1670.